Godavari Biorefineries Limited (GBL), one of the larger producers of ethanol and a global pioneer in manufacturing bio-based chemicals, has reported net loss of net loss of Rs 16.02 crore in quarter ended June 2025 as  against net loss of Rs 26.11 crore during the previous quarter ended June 2024. However, sales 2.05% to Rs 533.24 crore in the quarter ended June 2025 as against Rs 522.53 crore during the previous quarter ended June 2024. 

Commenting on the results, Samir Somaiya, CMD, said: “Q1 FY26 has been a quarter of resilience and progress for our Company. Despite the seasonality inherent in some of our segments, we delivered an improved performance with revenue from operations at ₹533.2 crore, an improvement over the same quarter last year, and achieved an EBITDA of ₹6.5 crore. Our BioBased Chemicals segment recorded a strong 43% year-on-year growth in EBITDA. 

On the ethanol front, from Sugar Season 2024-25 the restoration of the Ethanol Blending Program from Juice/Syrup helped us to produce more Ethanol from B heavy molasses. Our upcoming grain-based ethanol capacity will add a new growth lever. 

We are also proud to share significant progress in our Drug Discovery efforts. European patent for our novel anti-cancer molecule has been validated in Spain, the United Kingdom, and as a Unitary Patent covering multiple EU member states. Safety trials for the same molecule have been concluded without any dose limiting toxicity (DLT). 

Additionally, we have been granted a patent by the China National Intellectual Property Administration (CNIPA) for another novel anti-cancer molecule – HYDROXY-1,4-NAPHTHALENEDIONE. This patent covers a new class of compounds that have demonstrated strong inhibitory effects on cancer and cancer stem cells in vitro. These compounds have shown significant efficacy against multiple cancer types, including breast and prostate cancer. 

Looking ahead, our strategic focus remains on strengthening the bio-based chemicals segment through ongoing debottlenecking and the development of Bio-based specialty chemicals. In parallel, we are enhancing our multi-feedstock ethanol capabilities and investing in continuous research and development to drive long-term growth and innovation. With these initiatives, we remain confident of creating sustainable value for all stakeholders.”